Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	66.66	22.47	46.35	64.07	126.26
Short-Term Investments	171.3	147.56	92.01	22.68	26.01
Cash & Short-Term Investments	237.96	170.03	138.36	86.74	152.28
Cash Growth	39.95%	22.89%	59.50%	-43.04%	-43.95%
Receivables	3.47	1.01	0.03	0.01	0.4
Inventory	0.23	0.38	-	-	-
Prepaid Expenses	4.53	5.13	2.48	2.16	5.05
Total Current Assets	246.19	176.55	140.87	88.92	157.72
Property, Plant & Equipment	7.32	7.51	8.48	3.45	1.53
Goodwill	44.54	44.54	44.54	44.54	44.54
Other Long-Term Assets	0.37	0.83	0.41	-	-
Total Assets	298.42	229.43	194.3	136.91	203.79
Accounts Payable	14.8	14.39	10.4	9.15	5.47
Accrued Expenses	29.27	15.87	11.49	11.88	29.14
Current Portion of Long-Term Debt	-	-	-	-	11.65
Current Portion of Leases	1.18	1.29	1.29	1.09	0.55
Total Current Liabilities	45.25	31.55	23.17	22.12	46.81
Long-Term Debt	100.3	99.51	48.58	-	-
Long-Term Leases	4.6	5.27	5.42	1.19	0.61
Other Long-Term Liabilities	2.32	-	-	-	-
Total Liabilities	152.47	136.32	77.18	23.31	47.42
Common Stock	0.36	0.25	0.19	0.15	0.14
Additional Paid-In Capital	2,117	1,863	1,709	1,609	1,561
Retained Earnings	-1,967	-1,767	-1,590	-1,488	-1,400
Treasury Stock	-4.62	-2.89	-2.06	-7.52	-4.84
Comprehensive Income & Other	0.12	0.03	-0.43	-0.01	-0.01
Shareholders' Equity	145.95	93.11	117.12	113.6	156.37
Total Liabilities & Equity	298.42	229.43	194.3	136.91	203.79
Total Debt	106.07	106.06	55.29	2.28	12.81
Net Cash (Debt)	131.88	63.96	83.06	84.46	139.47
Net Cash Growth	106.19%	-23.00%	-1.66%	-39.44%	461.88%
Net Cash Per Share	0.41	0.29	0.50	0.58	1.26
Filing Date Shares Outstanding	361.49	246.24	188.73	149.59	143.56
Total Common Shares Outstanding	361.49	244.92	188.73	148.92	141.5
Working Capital	200.95	145	117.69	66.8	110.91
Book Value Per Share	0.40	0.38	0.62	0.76	1.11
Tangible Book Value	101.41	48.57	72.58	69.05	111.83
Tangible Book Value Per Share	0.28	0.20	0.38	0.46	0.79
Machinery	2.39	4.35	4	4.72	5.69
Leasehold Improvements	2.18	2.18	2.05	1.31	0.42

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q